MENU
+Compare
TNXP
Stock ticker: NASDAQ
AS OF
Apr 3, 01:40 PM (EDT)
Price
$17.16
Change
-$0.23 (-1.32%)
Capitalization
111.9M

TNXP Tonix Pharmaceuticals Holding Corp Forecast, Technical & Fundamental Analysis

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TNXP with price predictions
Apr 02, 2025

TNXP's Stochastic Oscillator remains in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 02, 2025. You may want to consider a long position or call options on TNXP as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for TNXP crossed bullishly above the 50-day moving average on March 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +6 3-day Advance, the price is estimated to grow further. Considering data from situations where TNXP advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 56 cases where TNXP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TNXP moved out of overbought territory on March 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for TNXP turned negative on April 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

TNXP moved below its 50-day moving average on March 31, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TNXP broke above its upper Bollinger Band on March 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.802) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.269) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TNXP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TNXP is expected to report earnings to rise 104.71% to -2000 cents per share on May 12

Tonix Pharmaceuticals Holding Corp TNXP Stock Earnings Reports
Q1'25
Est.
$-20.00
Q4'24
Missed
by $5.86
Q3'24
Beat
by $2.70
Q2'24
Missed
by $14.05
Q1'24
Beat
by $3.04
The last earnings report on March 18 showed earnings per share of -977 cents, missing the estimate of -391 cents. With 158.31K shares outstanding, the current market capitalization sits at 111.90M.
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMGGF0.170.01
+3.13%
DMG Blockchain Solutions Inc.
UBSFY2.290.02
+0.88%
UbiSoft Entertainment Inc.
SCMWY57.940.08
+0.14%
Swisscom AG
TCEHY64.02-0.56
-0.87%
Tencent Holding Ltd.
SSMXY18.43-0.46
-2.44%
Sysmex Corp.

TNXP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with ICU. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then ICU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-0.34%
ICU - TNXP
77%
Closely correlated
-10.00%
NEVPF - TNXP
36%
Loosely correlated
N/A
TOVX - TNXP
35%
Loosely correlated
+5.36%
CRVS - TNXP
32%
Poorly correlated
+1.26%
RNAZ - TNXP
28%
Poorly correlated
-2.29%
More

Groups containing TNXP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-0.34%
TNXP
(2 stocks)
100%
Closely correlated
-0.66%